Evaluation of the Effects of natural Pomegranate juice (Punica granatum) in patients with covid-19

Evaluation of the Effects of natural Pomegranate juice (Punica granatum) on CBC & inflammatory biomarkers in patients with covid-19: a Randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150711023153N2

Enrollment

Registered

2021-02-28

Start date

2021-02-28

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19. U07.1

Interventions

Intervention 1: Intervention group:Patients receiving 500 ml of natural pomegranate juice twice a day after lunch and after dinner + usual hospital medicine. Intervention 2: Placebo group: Patients re

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written informed consent form Age 18 years old or above COVID-19 diagnosis based on polymerase chain reaction (PCR) Acceptance for random assignment Willingness to participate in research study

Exclusion criteria

Exclusion criteria: Pregnancy or lactation IgA <61 mg/dl Disseminated intravascular coagulation or any other types of coagulopathy Severe congestive heart failure by the specialist Other contraindications prescribed by the specialist Participate in any clinical trial within the past 30 days prior to enrollment in the present study

Design outcomes

Primary

Measure	Time frame
Interleukin 6. Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.;CRP. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.;CBC. Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.	—

Measure

Time frame

Interleukin 6. Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.;CRP. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.;CBC. Timepoint: Before the intervention and at the end of day 14 of the study. Method of measurement: Elisa Kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmojtaba yousefi

Yasouj University of Medical Sciences

mojtaba.yousefi@yums.ac.ir+98 74 3322 5519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026